Effects of expiring reimbursability of pentaerythrityl tetranitrate (PETN, pentalong®) on anti-anginal therapy: an observational study

Efficacy of the long-acting nitro vasodilator pentaerithrityl tetranitrate in patients with chronic stable angina pectoris receiving anti-anginal background therapy with beta-blockers: a 12-week, randomized, double-blind, placebo-controlled trial

(2013) Thomas Münzel et al.   EUROPEAN HEART JOURNAL

2013 ESC guidelines on the management of stable coronary artery disease

(2013)   EUROPEAN HEART JOURNAL

2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary

(2012) Stephan D. Fihn et al.   CIRCULATION

Effect of the Market Withdrawal of Carisoprodol on Use of Other Prescribed Drugs With Abuse Potential

(2012) J G Bramness et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Management of stable angina: summary of NICE guidance: Figure 1

(2012) Robert A Henderson et al.   HEART

Feasibility Study of a Systematic Approach for Discontinuation of Multiple Medications in Older Adults

(2010) Doron Garfinkel et al.   ARCHIVES OF INTERNAL MEDICINE

Effects of pentaerythritol tetranitrate on endothelial function in coronary artery disease: results of the PENTA study

(2009) Boris Schnorbus et al.   Clinical Research in Cardiology